Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan +/- HCTZ Hypertension Extension
NCT00241007Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Dec 2003; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00241007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241007.